Advertisement
Screener

VYOME HOLDINGS, INC. (HIND) Weighted Average Number of Shares Outstanding, Basic and Diluted

2.8 / 5 stars · 68/120 Roast Me

VYOME HOLDINGS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted

VYOME HOLDINGS, INC. (HIND) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 8.23 million shares for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-16.

Discontinued › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-08-16

  • VYOME HOLDINGS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 8.23M shares, a 19.02% increase year-over-year.
  • VYOME HOLDINGS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 9.44M shares, a 22.25% increase year-over-year.
  • VYOME HOLDINGS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 7.77M shares, a 0.59% increase year-over-year.
  • VYOME HOLDINGS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 7.73M shares, a 27.51% increase year-over-year.
  • VYOME HOLDINGS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 7.74M shares, a 64.41% increase from fiscal 2019.
  • VYOME HOLDINGS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 4.71M shares, a 147.24% increase from fiscal 2018.
  • VYOME HOLDINGS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 1.90M shares, a 88.61% decline from fiscal 2017.
  • VYOME HOLDINGS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 16.72M shares, a 295.96% increase from fiscal 2016.
Period endWeighted Average Number of Shares Outstanding, Basic and Diluted 3 monthWeighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filedWeighted Average Number of Shares Outstanding, Basic and Diluted 6 monthWeighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filedWeighted Average Number of Shares Outstanding, Basic and Diluted 9 monthWeighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filedWeighted Average Number of Shares Outstanding, Basic and Diluted 12 monthWeighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed
2021-06-308.23M shares
10-Q · filed 2021-08-16
7.93M shares
10-Q · filed 2021-08-16
8.48M shares
derived: average of 3 quarters · filed 2021-08-16
8.29M shares
derived: average of 4 quarters · filed 2021-08-16
2021-03-319.44M shares
10-Q · filed 2021-05-12
8.61M shares
derived: average of 2 quarters · filed 2021-05-12
8.31M shares
derived: average of 3 quarters · filed 2021-05-12
7.96M shares
derived: average of 4 quarters · filed 2021-08-16
2020-12-317.77M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
7.75M shares
derived: average of 2 quarters · filed 2021-03-12
7.47M shares
derived: average of 3 quarters · filed 2021-08-16
7.74M shares
10-K · filed 2021-03-12
2020-09-307.73M shares
10-Q · filed 2020-11-06
7.32M shares
derived: average of 2 quarters · filed 2021-08-16
7.73M shares
10-Q · filed 2020-11-06
7.52M shares
derived: average of 4 quarters · filed 2021-08-16
2020-06-306.91M shares
10-Q · filed 2021-08-16
7.73M shares
10-Q · filed 2020-07-30
6.89M shares
10-Q · filed 2021-08-16
7.73M shares
10-Q · filed 2020-07-30
7.45M shares
derived: average of 3 quarters · filed 2021-08-16
7.11M shares
derived: average of 4 quarters · filed 2021-08-16
2020-03-317.73M shares
10-Q · filed 2021-05-12
7.73M shares
derived: average of 2 quarters · filed 2021-05-12
7.17M shares
derived: average of 3 quarters · filed 2021-05-12
6.05M shares
derived: average of 4 quarters · filed 2021-05-12
2019-12-317.73M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
6.89M shares
derived: average of 2 quarters · filed 2021-03-12
5.49M shares
derived: average of 3 quarters · filed 2021-03-12
4.71M shares
10-K · filed 2021-03-12
2019-09-306.06M shares
10-Q · filed 2020-11-06
4.37M shares
derived: average of 2 quarters · filed 2020-11-06
3.70M shares
10-Q · filed 2020-11-06
3.33M shares
derived: average of 4 quarters · filed 2020-11-06
2019-06-302.69M shares
10-Q · filed 2020-07-30
26.88M shares
10-Q · filed 2019-07-24
2.50M shares
10-Q · filed 2020-07-30
25.01M shares
10-Q · filed 2019-07-24
2.42M shares
derived: average of 3 quarters · filed 2020-07-30
2.30M shares
derived: average of 4 quarters · filed 2020-07-30
2019-03-312.31M shares
10-Q · filed 2020-06-19
23.11M shares
10-Q · filed 2019-05-10
2.29M shares
derived: average of 2 quarters · filed 2020-06-19
2.17M shares
derived: average of 3 quarters · filed 2020-06-19
5.89M shares
derived: average of 4 quarters · filed 2020-06-19
2018-12-312.26M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
2.10M shares
derived: average of 2 quarters · filed 2020-02-27
7.08M shares
derived: average of 3 quarters · filed 2020-02-27
1.90M shares
10-K · filed 2020-02-27
19.04M shares
10-K · filed 2019-02-22
2018-09-301.95M shares
10-Q · filed 2019-11-08
19.46M shares
10-Q · filed 2018-11-02
9.49M shares
derived: average of 2 quarters · filed 2019-11-08
1.78M shares
10-Q · filed 2019-11-08
17.84M shares
10-Q · filed 2018-11-02
13.22M shares
derived: average of 4 quarters · filed 2019-11-08
2018-06-3017.04M shares
10-Q · filed 2019-07-24
17.01M shares
10-Q · filed 2019-07-24
16.98M shares
derived: average of 3 quarters · filed 2019-07-24
16.92M shares
derived: average of 4 quarters · filed 2019-07-24
2018-03-3116.99M shares
10-Q · filed 2019-05-10
16.95M shares
derived: average of 2 quarters · filed 2019-05-10
16.88M shares
derived: average of 3 quarters · filed 2019-05-10
16.82M shares
derived: average of 4 quarters · filed 2019-05-10
2017-12-3116.92M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22
16.83M shares
derived: average of 2 quarters · filed 2019-02-22
16.77M shares
derived: average of 3 quarters · filed 2019-02-22
16.72M shares
10-K · filed 2019-02-22
2017-09-3016.75M shares
10-Q · filed 2018-11-02
16.69M shares
derived: average of 2 quarters · filed 2018-11-02
16.65M shares
10-Q · filed 2018-11-02
16.18M shares
derived: average of 4 quarters · filed 2018-11-02
2017-06-3016.64M shares
10-Q · filed 2018-08-02
16.60M shares
10-Q · filed 2018-08-02
15.99M shares
derived: average of 3 quarters · filed 2018-08-02
12.23M shares
derived: average of 4 quarters · filed 2018-08-02
2017-03-3116.56M shares
10-Q · filed 2018-05-10
15.66M shares
derived: average of 2 quarters · filed 2018-05-10
10.76M shares
derived: average of 3 quarters · filed 2018-05-10
8.22M shares
derived: average of 4 quarters · filed 2018-05-10
2016-12-3114.77M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05
7.87M shares
derived: average of 2 quarters · filed 2018-03-05
5.44M shares
derived: average of 3 quarters · filed 2018-03-05
4.22M shares
10-K · filed 2018-03-05
2016-09-30963.72K shares
10-Q · filed 2017-11-03
770.69K shares
derived: average of 2 quarters · filed 2017-11-03
706.69K shares
10-Q · filed 2017-11-03
672.88K shares
derived: average of 4 quarters · filed 2018-03-05
2016-06-30577.66K shares
10-Q · filed 2017-08-02
576.76K shares
10-Q · filed 2017-08-02
575.93K shares
derived: average of 3 quarters · filed 2018-03-05
575.46K shares
derived: average of 4 quarters · filed 2018-03-05
2016-03-31575.86K shares
10-Q · filed 2017-05-10
575.06K shares
derived: average of 2 quarters · filed 2018-03-05
574.72K shares
derived: average of 3 quarters · filed 2018-03-05
2015-12-31574.27K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05
574.16K shares
derived: average of 2 quarters · filed 2018-03-05
573.18K shares
10-K · filed 2018-03-05
2015-09-30574.04K shares
10-Q · filed 2016-11-10
572.82K shares
10-Q · filed 2016-11-10
2014-12-31531.43K shares
10-K · filed 2017-02-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36